We present a case of a critically ill patient with coronavirus disease 2019 (COVID-19) found to have acquired immune deficiency syndrome and Pneumocystis jirovecii pneumonia (PCP). Coronavirus disease 2019 and PCP co-occurrence is increasingly reported and may complicate diagnostic and therapeutic strategies. Patients with severe COVID-19 should be screened for underlying immunocompromise and coinfections should be considered
The advent of HIV and AIDS has brought about many diagnostic and management challenges regarding mul...
Pneumocystis jirovecii, is an opportunistic fungal agent that causes pneumonia (pneumocistosis) that...
Background We conducted this study to assess the prevalence of viral coinfection in a well character...
Cases of Pneumocystis jirovecii pneumonia (PCP) in patients suffering from COVID-19 were described i...
Cases of Pneumocystis jirovecii pneumonia (PCP) in patients suffering from COVID-19 were described i...
BACKGROUND: The spectrum of clinical manifestations and differential diagnosis associated with coron...
While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment f...
Pneumocystis jirovecii pneumonia (PCP), caused by fungal species named Pneumocystis jirovecii, is a ...
Background: Several cases of invasive fungal diseases in patients with COVID-19 have been reported, ...
Coronavirus disease 2019 (COVID‐19) and pneumocystis pneumonia share many overlapping features and m...
Key Clinical Message Although immunodeficient patients are less prone to develop Coronavirus disease...
Introduction: Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jiro...
Background: Pneumocystis jirovecii pneumonia (PCP) and SARS-CoV2 share some similarities in their ef...
A 60-year-old male presented to the emergency department (ED) with a 1–2 day history of confusion, h...
The World Health Organization has declared novel coronavirus disease 2019 (COVID-19) an internationa...
The advent of HIV and AIDS has brought about many diagnostic and management challenges regarding mul...
Pneumocystis jirovecii, is an opportunistic fungal agent that causes pneumonia (pneumocistosis) that...
Background We conducted this study to assess the prevalence of viral coinfection in a well character...
Cases of Pneumocystis jirovecii pneumonia (PCP) in patients suffering from COVID-19 were described i...
Cases of Pneumocystis jirovecii pneumonia (PCP) in patients suffering from COVID-19 were described i...
BACKGROUND: The spectrum of clinical manifestations and differential diagnosis associated with coron...
While clinical environments are highly focused on COVID-19, reports of missed or delayed treatment f...
Pneumocystis jirovecii pneumonia (PCP), caused by fungal species named Pneumocystis jirovecii, is a ...
Background: Several cases of invasive fungal diseases in patients with COVID-19 have been reported, ...
Coronavirus disease 2019 (COVID‐19) and pneumocystis pneumonia share many overlapping features and m...
Key Clinical Message Although immunodeficient patients are less prone to develop Coronavirus disease...
Introduction: Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis jiro...
Background: Pneumocystis jirovecii pneumonia (PCP) and SARS-CoV2 share some similarities in their ef...
A 60-year-old male presented to the emergency department (ED) with a 1–2 day history of confusion, h...
The World Health Organization has declared novel coronavirus disease 2019 (COVID-19) an internationa...
The advent of HIV and AIDS has brought about many diagnostic and management challenges regarding mul...
Pneumocystis jirovecii, is an opportunistic fungal agent that causes pneumonia (pneumocistosis) that...
Background We conducted this study to assess the prevalence of viral coinfection in a well character...